Emergent signs deal to make British COVID-19 vaccineAstraZeneca in June picked Emergent to help produce 300 million doses of its potential COVID-19 vaccine pledged to the United States.Scientists develop a vaccine against the coronavirus disease in Saint Petersburg(photo credit: REUTERS)
